Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

1200014J11Rik Activators

1200014J11Rik Activators encompass a series of chemical compounds that indirectly promote the functional activity of 1200014J11Rik through distinct cellular signaling pathways. Forskolin and IBMX both elevate intracellular cAMP, which in turn activates PKA, a kinase that may phosphorylate proteins involved in the regulatory processes affecting 1200014J11Rik, thereby enhancing its activity. Similarly, PMA activates PKC, which could phosphorylate intermediates that modulate 1200014J11Rik function. EGCG, as a kinase inhibitor, reduces the activity of competitive. 1200014J11Rik Activators are a diverse set of chemical compounds that indirectly catalyze the functional activity of 1200014J11Rik through modulation of various signaling pathways. Forskolin, by raising cAMP levels, and IBMX, by inhibiting cAMP degradation, both enhance PKA activity. PKA can phosphorylate regulators that interact with 1200014J11Rik, leading to its activation.

PMA, through PKC activation, and Epigallocatechin gallate (EGCG), by inhibiting competitive kinases, foster an environment that augments the activity of 1200014J11Rik. LY294002 and Wortmannin, both PI3K inhibitors, may indirectly boost 1200014J11Rik activity by shifting balance towards alternative signaling pathways that enhance its function. Thapsigargin, by disrupting calcium homeostasis, and A23187, as a calcium ionophore, both raise intracellular calcium levels, which could activate calcium-dependent pathways enhancing 1200014J11Rik's role. Continuing the pathway-specific focus, S1P, by interacting with its receptors, can initiate signaling cascades that activate mechanisms involving 1200014J11Rik. U0126 and SB203580, which inhibit MEK1/2 and p38 MAPK respectively, may redirect signaling to pathways that upregulate 1200014J11Rik activity. Genistein's inhibition of tyrosine kinases potentially decreases competitive signaling, allowing pathways that interact with 1200014J11Rik to be more active. Collectively, these compounds, through their targeted effects on cellular signaling, facilitate the enhancement of 1200014J11Rik-mediated functions by influencing the activity of the protein without directly modifying its expression levels or relying on direct activators.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP. By preventing cAMP breakdown, IBMX indirectly sustains the activation of cAMP-dependent pathways, which may increase the activity of 1200014J11Rik through enhanced PKA signaling.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a potent activator of protein kinase C (PKC). Activation of PKC leads to phosphorylation of target proteins that may interact with or modulate the activity of 1200014J11Rik, thereby enhancing its function.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known for its ability to inhibit certain protein kinases. This inhibition can reduce competitive signaling, allowing for enhanced activation of pathways that directly upregulate the activity of 1200014J11Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. By inhibiting PI3K and downstream Akt signaling, it may lead to a compensatory upregulation of alternative pathways, potentially enhancing the activity of 1200014J11Rik.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that by blocking PI3K can shift cellular signaling towards pathways that activate 1200014J11Rik, leading to its functional enhancement.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). This leads to a rise in cytosolic calcium levels, which may activate calcium-dependent signaling pathways that enhance the function of 1200014J11Rik.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

S1P engages with its receptors to initiate signaling cascades that can lead to the activation of pathways involving 1200014J11Rik, thereby increasing its activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a selective inhibitor of p38 MAPK. Inhibition of p38 may lead to activation of alternative signaling routes that enhance the functional activity of 1200014J11Rik.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor. By blocking tyrosine kinase activity, it may reduce competitive signaling and indirectly augment the activation of pathways involving 1200014J11Rik.